EP2987458B1 - Mikrofrakturvorrichtungen - Google Patents
Mikrofrakturvorrichtungen Download PDFInfo
- Publication number
- EP2987458B1 EP2987458B1 EP15185091.4A EP15185091A EP2987458B1 EP 2987458 B1 EP2987458 B1 EP 2987458B1 EP 15185091 A EP15185091 A EP 15185091A EP 2987458 B1 EP2987458 B1 EP 2987458B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- penetrator
- transverse dimension
- cannula
- penetration
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000013201 Stress fracture Diseases 0.000 title claims description 33
- 230000035515 penetration Effects 0.000 claims description 125
- 210000000988 bone and bone Anatomy 0.000 claims description 36
- 210000005065 subchondral bone plate Anatomy 0.000 claims description 27
- 238000000576 coating method Methods 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 11
- 239000010935 stainless steel Substances 0.000 claims description 8
- 229910001220 stainless steel Inorganic materials 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 4
- 229910000619 316 stainless steel Inorganic materials 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- -1 silver ions Chemical class 0.000 claims description 3
- 238000000034 method Methods 0.000 description 22
- 241001631457 Cannula Species 0.000 description 12
- 210000003127 knee Anatomy 0.000 description 9
- 238000011282 treatment Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000005452 bending Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 210000000323 shoulder joint Anatomy 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010061762 Chondropathy Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 201000009859 Osteochondrosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000022159 cartilage development Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 210000004285 patellofemoral joint Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229910000811 surgical stainless steel Inorganic materials 0.000 description 1
- 239000010966 surgical stainless steel Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1604—Chisels; Rongeurs; Punches; Stamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1662—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body
- A61B17/1675—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body for the knee
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/17—Guides or aligning means for drills, mills, pins or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/03—Automatic limiting or abutting means, e.g. for safety
- A61B2090/033—Abutting means, stops, e.g. abutting on tissue or skin
- A61B2090/034—Abutting means, stops, e.g. abutting on tissue or skin abutting on parts of the device itself
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
Definitions
- the present invention relates generally to orthopedic treatments, more particularly, but not by way of limitation, to devices and methods for creating microfractures (e.g., in subchondral bone).
- US 2010/0191195 A1 discloses cannulated microfracture systems with a trocar having a proximal contact tip ends, a threadably adjustable striker system with a striker member on a distal end thereof and a handle member or a grip.
- US 2004/0147932A1 discloses a pneumatically driven orthopedic microfracture instrument.
- the instrument moves a fracture pin to the end of a guide tube until a sharp end punctures or penetrates a subchondral bone plate and thereby creates a microfracture or hole therein.
- EP 0082 081 A1 discloses a needle for acupuncture made of stainless steel with a plane section in the vicinity of the needles proximal end. The surface of the needle is coated by a metal or conducting alloy.
- WO 2011/014677 A1 discloses an instrument to create microfractures in subchondral bone with an outer sleeve having a handle coupled to a hollow tube. The end of the tube is curved and configured to secure the end on a subchondral bone. A puncture element can be inserted through the outer sleeve into the subchondral bone.
- the present invention provides an apparatus according to claim 1 and an kit according to claim 17.
- Preferred embodiments are subjects of the dependent claims 2 to 16.
- This disclosure includes embodiments of apparatuses and kits for creating microfractures in bone (e.g., subchondral bone). At least some of the present embodiments are configured to create a microfracture with a greater depth-to-width ratio than has been possible with known methods and apparatuses.
- bone e.g., subchondral bone
- some embodiments are configured to create a microfracture in subchondral bone having a (e.g., first) transverse dimension (e.g., diameter) of less than 1.2 millimeters (mm) (e.g., between 1 mm and 1.1 mm, less than 1.1 mm, less than 1.05 mm, less than 1 mm), and a depth (or length) of at least 5 mm (e.g., 7 mm, 8 mm, 8-10 mm, or the like).
- a transverse dimension e.g., diameter
- mm millimeters
- Some embodiments of the present apparatuses comprise: a cannula having a first end, a second end, and a channel extending between the first end and the second end; and a penetrator having a distal end and a (e.g., first) transverse dimension of less than 1.2 millimeters (mm) (e.g., between 1 mm and 1.1 mm, less than 1.1 mm, less than 1.05 mm, less than 1 mm), the penetrator configured to be disposed in the channel of the cannula such that the penetrator is movable between a retracted position and an extended position in which the distal end extends beyond the second end of the cannula by a penetration distance of at least 5 mm; where the penetrator is configured to be moved from the retracted position to the extended position substantially without rotation of the penetrator to form in subchondral bone a microfracture having a depth of at least 5 mm.
- mm millimeters
- the cannula has a primary portion and a distal portion between the primary portion and the second end, the distal portion configured such that a second end of the channel is disposed at an angle relative to a first end of the channel.
- the transverse dimension of the penetrator is less than 1.1 millimeters (mm).
- the penetrator is configured to be manually moved from the retracted position to the extended position.
- the penetrator has an enlarged head, and the penetration distance is limited by the enlarged head contacting the cannula.
- the penetrator comprises an elongated body and an enlarged head coupled to the elongated body.
- the enlarged head is unitary with the elongated body.
- the cannula includes a recessed portion and a shelf, the recessed portion extending from the first end of the cannula toward the second end of the cannula, the shelf disposed between the recessed portion and the second end of the cannula such that the penetration distance is limited by the enlarged head contacting the shelf.
- the recessed portion has a depth that is at least as large as the penetration distance.
- the enlarged head has a cylindrical shape with a length and a transverse dimension that is smaller than the length.
- the enlarged head has a transverse dimension that is at least 90% of a corresponding transverse dimension of the recessed portion.
- the distal end of the penetrator is pointed.
- the penetrator comprises at least one of a biocompatible metal, nickel-titanium alloy, stainless steel, and 316L stainless steel.
- a coating is disposed on at least the penetration portion of the penetrator.
- the coating is hydrophilic.
- the coating comprises silver ions.
- the penetrator includes a primary portion and a penetration portion, the primary portion having a circular cross-section, the penetration portion disposed between the primary portion and the distal end, the penetration portion having a circular cross-section that is smaller than the circular cross-section of the primary portion.
- the first transverse dimension is in the penetration portion, and a second transverse dimension smaller than the first dimension is between the first transverse dimension and the primary portion.
- the penetration portion has a length and the second transverse dimension is substantially constant along part of the length of the penetration portion.
- the penetration portion includes a narrow portion with at least one transverse dimension that is less than an adjacent transverse dimension of the penetration portion, such that the narrow portion is configured to reduce contact between the penetrator and a bone if the penetration portion is inserted into bone.
- the penetrator includes a primary portion and a penetration portion disposed between the primary portion and the distal end, the first transverse dimension is in the penetration portion, and a second transverse dimension is between the first transverse dimension and the primary portion. In some embodiments, the second transverse dimension is smaller than the first transverse dimension. In some embodiments, the penetration portion has a length, and the second transverse dimension is substantially constant along part of the length of the penetration portion. In some embodiments, the first transverse dimension is closer to the distal end than to the primary portion.
- the penetrator has a first cross-sectional area at the first transverse dimension, the penetrator has a second cross-sectional area at the second transverse dimension, and the first cross-sectional area is larger than the second cross-sectional area. In some embodiments, the penetrator has a first circular cross section at the first transverse dimension, and the penetrator has a second circular cross section at the second transverse dimension.
- the distal end includes a pointed tip with a cross-sectional shape defined by a tip angle of 60 degrees or greater.
- the tip angle is bisected by a central longitudinal axis of the penetration portion.
- the tip angle is greater than 90 degrees.
- the tip angle is greater than 120 degrees (e.g., 180 degrees, such that the tip is flat or at a right-angle to the longitudinal axis of the end of the penetration portion rather than pointed).
- the tip can be rounded.
- Some embodiments further comprise: a penetrator removal tab coupled to the penetrator and configured to retract the penetrator relative to the cannula.
- the cannula includes a handle, the penetrator includes a flange, the penetrator removal tab includes an opening that is has at least one transverse dimension that is smaller than a transverse dimension of the flange; and the penetrator removal tab is configured to be disposed between the handle and the flange with the penetrator extending through the opening.
- the penetrator removal tab includes a protrusion configured to extend toward the second end of the cannula and contact the handle to act as a fulcrum for pivoting the penetrator removal tab.
- the cannula comprises a handle having an indicator indicative of the position of the distal portion of the cannula.
- kits comprise: any embodiment of the present apparatuses, where the penetrator is a first penetrator; and a second penetrator having a distal end and a transverse dimension of less than 1.2 millimeters (mm) (e.g., between 1 mm and 1.1 mm, less than 1.1 mm, less than 1.05 mm, less than 1 mm), the second penetrator configured to be disposed in the channel of the cannula such that the second penetrator is movable between a retracted position and an extended position in which the distal end of the second penetrator extends beyond the second end of the cannula by a second penetrator penetration distance that is at least 5 mm and different than the penetration distance of the first penetrator.
- mm millimeters
- Corresponding methods may comprise: disposing a microfracture apparatus adjacent to the subchondral bone (the microfracture apparatus comprising: a cannula having a first end, a second end, and a channel extending between the first end and the second end; and a penetrator having a distal end and a transverse dimension of less than 1.2 millimeter (mm) (e.g., between 1 mm and 1.1 mm, less than 1.1 mm, less than 1.05 mm, less than 1 mm)); and advancing the penetrator relative to the cannula, substantially without rotation of the penetrator, until the distal end of the penetrator extends into the subchondral bone to form a microfracture having a depth greater than 5 mm.
- mm millimeter
- Some embodiments further comprise: repeating the steps of disposing and advancing to form a plurality of microfractures in the subchondral bone.
- the apparatus further comprises a penetrator removal tab coupled to the penetrator and configured to retract the penetrator relative to the cannula, and the method further comprises: actuating the penetrator removal tab to retract the distal end of the penetrator from the bone.
- the cannula includes a handle, the penetrator includes a flange, the penetrator removal tab includes an opening that is has at least one transverse dimension that is smaller than a transverse dimension of the flange; and the penetrator removal tab is configured to be disposed between the handle and the flange with the penetrator extending through the opening.
- the penetrator removal tab includes a protrusion configured to extend toward the second end of the cannula and contact the handle to act as a fulcrum for pivoting the penetrator removal tab, and actuating the penetrator removal tab includes pivoting the penetrator removal tab around a point of contact between the protrusion and the handle.
- the cannula comprises a handle having an indicator indicative of the position of the distal portion of the cannula.
- the microfracture apparatus is disposed such that the second end of the cannula contacts the subchondral bone.
- the penetrator is advanced manually.
- the position of the second end of the cannula relative to the bone is substantially constant while advancing the penetrator.
- the penetrator has an enlarged head, and the penetration distance is limited by the enlarged head contacting the cannula.
- the cannula includes a recessed portion and a shelf, the recessed portion extending from the first end of the cannula toward the second end of the cannula, the shelf disposed between the recessed portion and the second end of the cannula such that the penetration distance is limited by the enlarged head contacting the shelf.
- the recessed portion has a depth that is at least as large as the penetration distance.
- the enlarged head has a cylindrical shape with a length and a transverse dimension that is smaller than the length. In some embodiments, the enlarged head has a transverse dimension that is at least 90% of a corresponding transverse dimension of the recessed portion. In some embodiments, the distal end of the penetrator is pointed. In some embodiments, the penetrator includes a primary portion and a penetration portion, the primary portion having a circular cross-section, the penetration portion disposed between the primary portion and the distal end, the penetration portion having a circular cross-section that is smaller than the circular cross-section of the primary portion.
- any embodiment of any of the present apparatuses and methods can consist of or consist essentially of - rather than comprise/include/contain/have - any of the described steps, elements, and/or features.
- the term “consisting of' or “consisting essentially of' can be substituted for any of the open-ended linking verbs recited above, in order to change the scope of a given claim from what it would otherwise be using the open-ended linking verb.
- Coupled is defined as connected, although not necessarily directly, and not necessarily mechanically; two items that are “coupled” may be unitary with each other.
- the terms “a” and “an” are defined as one or more unless this disclosure explicitly requires otherwise.
- the term “substantially” is defined as largely but not necessarily wholly what is specified (and includes what is specified; e.g., substantially 90 degrees includes 90 degrees and substantially parallel includes parallel), as understood by a person of ordinary skill in the art. In any embodiment of the present apparatuses, kits, and methods, the term “substantially” may be substituted with "within [a percentage] of' what is specified, where the percentage includes 0.1, 1, 5, and/or 10 percent.
- an apparatus, device or system that is configured in a certain way is configured in at least that way, but it can also be configured in other ways than those specifically described.
- apparatus 10 comprises a penetrator 14, a cannula 18, and a handle 22 coupled to cannula 18.
- handle 22 may be omitted.
- cannula 18 has a first end 26, a second end 30, and a channel 34 extending between the first end and the second end. Such first and second ends should be understood as the locations of the beginning and end of the channel.
- cannula 18 has a primary portion 38 and a distal portion 42, with primary portion 38 extending between first end 26 and distal portion 42 (e.g., a majority of the length of the cannula, as in the embodiment shown), and with distal portion 42 extending between primary portion 38 and second end 30.
- the distal portion can be configured such that a second end of the channel (at second end 30) is disposed at an angle relative to a first end of the channel (at first end 26).
- distal portion 42 is disposed at an angle 46 relative to the primary portion. In the embodiment shown, angle 46 is between 10 and 30 degrees (e.g., 20 degrees).
- angle 46 can be any size that permits apparatus 10 to function as described in this disclosure (e.g., angle 46 can be equal to, or between any two of: 0, 10, 20, 30, 40, 45, 50, and/or 60 degrees). In other embodiments, angle 46 can be greater than 60 degrees (e.g., equal to, or between any two of: 60, 70, 80, 90, and/or more degrees). As a further example, distal portion 42 can include a curved or hooked shape such that angle 46 is effectively larger than 90 degrees (e.g., equal to, or between any two of: 90, 120, 150, 180, and/or 180 degrees).
- Penetrator 14 and cannula 18 can comprise any suitable material that permits the apparatus to function as described in this disclosure (e.g., and permits the penetrator and the cannula to be sterilized).
- penetrator 14 comprises nickel-titanium alloy (e.g., Nitinol), and/or cannula 18 comprises metal, such as stainless steel (e.g., a surgical stainless steel).
- Nitinol nickel-titanium alloy
- cannula 18 comprises metal, such as stainless steel (e.g., a surgical stainless steel).
- Embodiments of the present cannulas are rigid and configured not to flex or bend during use.
- penetrator 14 can comprise a biocompatible metal such as stainless steel (e.g., 316L stainless steel).
- penetrator 14 has a proximal end 54, an enlarged head 58 adjacent proximal end 54, a primary portion 62, a distal end 66 (e.g., pointed distal end 66, as shown), and a penetration portion 70 adjacent distal end 66.
- penetration portion 70 has a length 74 that is a minority of the length of penetrator 14 between proximal end 54 and distal end 66.
- penetrator 14 has a transverse dimension of less than 1.2 mm (e.g., between 1 mm and 1.1 mm; less than 1.1 mm, less than 1.05 mm, less than 1 mm; less than, or between any two of, 0.5, 0.6, 0.7, 0.8, 0.9, and/or 1 mm).
- penetration portion 70 has a circular cross-section with a diameter 78 of between 0.7 and 0.8 mm (e.g., 0.78 mm).
- penetration portion 70 has a circular cross-section with a diameter of between 1 and 1.1 mm (e.g., 1.04 mm).
- Penetrator 14 is configured to be disposed in channel 34 of cannula 18 such that penetrator 14 is movable between a (1) retracted position (e.g., in which distal end 66 of the penetrator does not extend beyond second end 30 of the cannula) and (2) an extended position in which distal end 66 of the penetrator extends beyond second end 30 of the cannula by a penetration distance 82.
- penetration distance 82 is at least (e.g., greater than) 5 mm (e.g., 7 mm, 8 mm, 8-10 mm, more than 10 mm) and/or at least (e.g., greater than) 5 times (e.g., greater than, or between any two of: 6, 7, 8, 9, 10, or more times) a transverse dimension (e.g., diameter) of penetrator 14 (e.g., diameter 78 of penetration portion 70).
- a transverse dimension e.g., diameter of penetrator 14
- penetration distance 82 is between 8 mm and 10 mm (e.g., 10 mm), which is greater than 12 times diameter 78.
- diameter 50 of primary portion 38 is larger than diameter 78 of penetration portion 70.
- diameter 50 is also less than 1.2 mm (e.g., between 1 mm and 1.1 mm, less than 1.1 mm, less than 1.05 mm). In some embodiments, diameter 50 is substantially equal to diameter 78. In some embodiments, penetrator 14 comprises a central wire defining diameter 78 that is encircled or encased by an outer tubing (e.g., metallic tubing, plastic shrink wrap, and/or the like along the length of primary portion 62 to define transverse dimension 50.
- an outer tubing e.g., metallic tubing, plastic shrink wrap, and/or the like along the length of primary portion 62 to define transverse dimension 50.
- a coating is disposed on at least penetration portion 70 of penetrator 14 (the coating may also be disposed on primary portion 62 of the penetrator).
- the coating is hydrophilic. Examples of hydrophilic coatings include Hydro-Silk coatings available from TUA Systems of Florida (U.S.A.).
- the coating comprises silver ions.
- the coating comprises one or more active ingredients configured to elicit or stimulate a biological response in (e.g., bone or cartilage) tissue, such as, for example, growth factor(s), anticoagulant(s), protein(s), and/or the like. Such coatings can be applied as known in the art for the materials used in particular embodiments.
- cannula 18 is configured to provide lateral support for penetrator 14, such as to prevent the penetrator from bending or buckling while being driven into the hard subchondral bone.
- diameter 50 of primary portion 62 of the penetrator is nearly as large as (e.g., greater than, or between any two of: 95, 96, 97, 98, 99, and or 100 percent of) the diameter of channel 34, and diameter 78 of penetration portion 70 is greater than 75% (e.g., greater than, or between any two of: 75, 80, 85, 90, 95, and/or 100 percent of) the diameter of channel 34 (e.g., the diameter of channel 34 adjacent second end 30 of the cannula).
- penetrator 14 is substantially straight prior to being disposed in channel 34 of cannula 18, such that inserting the penetrator into the cannula causes the penetration portion 70 of the penetrator to be angled relative to primary portion 62.
- penetrator 14 may be resilient enough to (e.g., at least partially) return to its straight shape after removal from the cannula.
- penetrator 14 is configured to be moved or advanced (e.g., substantially without rotation of the penetrator) from the retracted position to the extended position ( FIG. 2B ) to form a microfracture in subchondral bone (e.g., in a patient's knee or shoulder joint), the microfracture having a depth of at least (e.g., more than) 5 mm (e.g., 7 mm, 8 mm, 8-10 mm, more than 10 mm) and/or at least (e.g., greater than) 5 times (e.g., greater than, or between any two of: 6, 7, 8, 9, 10, or more times) a transverse dimension (e.g., diameter) of penetrator 14 (e.g., diameter 78 of penetration portion 70).
- a transverse dimension e.g., diameter
- penetrator 14 is configured to be moved or advanced (e.g., substantially without rotation of the penetrator, which includes no rotation up to rotation of less than one full revolution clockwise and/or counterclockwise from the position at which distal end 66 of the penetrator first contacts the bone) from the retracted position to the extended position ( FIG. 2B ) to form a microfracture in subchondral bone (e.g., in a patient's knee or shoulder joint), the microfracture having a depth of between 8 mm and 10 mm (e.g., 10 mm), which is greater than 12 times diameter 78.
- penetrator 14 is configured to be moved or advanced manually to the extended position.
- moved or advanced means without the assistance of an external energy source other than that provided by a user.
- the penetrator would not be “manually.”
- the penetrator would be moved or advanced “manually” if a mallet, hammer, or other tool is swung by a user (e.g., in the user's hand) to impact first end 26 of the penetrator.
- the present apparatuses are configured such that the penetrator can (but need not) be rotated as it is advanced or moved from the retracted position to the advanced position.
- a portion of the penetrator (e.g., enlarged head 58) can be disposed in the chuck of a drill such that the drill can rotate the penetrator.
- the penetrator may (but need not) be substantially straight or axial (without bends) along its entire length (e.g., prior to being disposed in a cannula with an angled distal portion).
- penetration distance 82 (and the depth of the microfracture the apparatus is configured to create) is limited by enlarged head 58 contacting the cannula (e.g., penetration distance is maximized when enlarged head 58 contacts the cannula, as shown in FIG. 2B ).
- cannula 18 includes a recessed portion 86 and a shelf 90. As shown, recessed portion 86 extends from first end 26 toward second end 30 (inwardly), and shelf 90 is disposed between recessed portion 86 and second end 30 such that penetration distance 82 is limited by enlarged head 58 contacting shelf 90.
- enlarged head 58 has a cylindrical (e.g., circular cylindrical, as shown) with a first end 94 and a second end 98, and is configured such that second end 98 contacts shelf 90 when the penetrator is in the extended position relative to the cannula ( FIG. 2B ).
- recessed portion 86 can be configured to maintain the orientation or alignment of enlarged head 58 as the penetrator is moved or advanced from the retracted position to the extended position.
- recessed portion 58 has a depth 102 that is at least as large as (e.g., is greater than, or between any two of: 100, 110, 120, 130, 140, 150, or more percent of) penetration distance 82 (e.g., such that enlarged head 58 is at least partially within recessed portion 86 when distal end 66 extends beyond second end 30 of the cannula), and/or enlarged head 58 has a transverse dimension (e.g., diameter) that is at least 90% (e.g., greater than, or between any two of: 90, 92, 94, 96, 98, and/or 100 percent) of a corresponding transverse dimension of recessed portion 86 (e.g., such that cannula 18 limits tilting of enlarged head 58 relative to cannula 14, and/or limits misalignment of enlarged head 58 relative to primary portion 62 of the penetrator).
- a transverse dimension e.g., diameter
- depth 102 of recessed portion 58 is between 175% and 250% (e.g., between 200% and 225%) of penetration distance 82.
- enlarged head 58 and recessed portion 86 each has a circular cross section, and enlarged head 58 has a diameter 106 that is between 90% and 100% (e.g., between 95% and 100%) of diameter 110 of recessed portion 86.
- a length 114 of enlarged head 58 is at least 150% (e.g., at least, or between any two of: 150, 175, 200, 225, 250, 300, or more percent) of penetration distance 82.
- length 114 is over 300% of penetration distance 82, such that a portion of enlarged head 58 that is at least as long as penetration distance 82 is disposed in recessed portion 86 when distal end 66 of the penetrator is even with second end 30 of the cannula (and the orientation of enlarged head 58 relative to cannula 18 is thereby maintained).
- enlarged head 58 has an elongated shape such that length 114 is greater than (e.g., greater than, or between any two of: 2, 3, 4, 6, 8, or more times) diameter 106.
- length 114 is between 8 and 12 times diameter 106.
- FIG. 3 depicts a second embodiment 10a of the present apparatuses.
- Apparatus 10a is substantially similar to apparatus 10, with the exception that apparatus 10a does not include a handle (e.g., handle 22).
- Embodiments of the present kits can comprise one or more of the present cannulas (e.g., cannula 14) and a reusable tray or other container in a package (e.g., a sealed pouch or the like), where both the cannula(s) and the tray are or can be sterilized (and can be re-sterilized in advance of being re-used). Both the tray and the package may be rectangular in shape.
- some embodiments of the present kits can also include two or more penetrators configured to create different microfractures.
- some embodiments of the present kits comprise one or more of the present cannulas, a sterlizable tray, a first penetrator configured to have a penetration distance of between 5 mm and 8 mm when used in combination with the cannula, and a second penetrator configured to have a penetration distance greater than 8 mm when used in combination with the cannula.
- some embodiments of the present kits may include a package (e.g., a box or a flexible package) that comprises sterilized versions of these items.
- kits comprise one or more of the present penetrators (e.g., a single penetrator or two penetrators having different penetration depths, different tip diameters, different tip shapes, and/or the like) that are sterile and disposed in a package.
- Embodiments of the present kits may also include, in more specific embodiments, instructions for use, which instructions may be inside the package (e.g., as an insert) or outside the package (such as a sticker on the package).
- FIGS. 4A and 4B depict an example of the present methods (e.g., using embodiment 10a of the present apparatuses).
- Some embodiments of the present methods comprise: disposing an embodiment of the present microfracture apparatuses (e.g., 10, 10a) adjacent to subchondral bone of a patient (e.g., in the knee, shoulder, or other joint).
- apparatus 10a is disposed adjacent to subchondral bone of articular surface 150 in a patient's knee 154 (e.g., with second end 30 of cannula 18 in contact with the subchondral bone, as shown).
- Some embodiments further comprise moving or advancing penetrator 14 relative to cannula 18 (e.g., from FIG. 4A to FIG.
- penetrator 18 is manually advanced substantially without rotation of the penetrator by striking or impacting proximal end 54 of the penetrator with a mallet 158 until distal end 66 extends into the subchondral bone by a distance of, and forms a microfracture 162 having a depth of, 10 mm.
- the position of second end 30 of the cannula relative to the subchondral bone remains substantially constant while advancing the penetrator into the bone.
- the apparatus is repeatedly disposed adjacent the bone (e.g., with second end 30 of the cannula in contact with the subchondral bone and/or in contact with cartilage, such as, for example, cartilage around the perimeter of a lesion), and the penetrator is repeatedly advanced into the subchondral bone to form a plurality of microfractures (e.g., having substantially the same depths).
- the present methods can be performed on and/or in the surfaces of other joints, such as, for example, the shoulder, the ankle, the hip, and/or the patellofemoral joint within the knee.
- Penetrator 14a is similar in many respects to penetrator 14.
- penetrator 14a has a proximal end 54, a primary portion 62, a distal end 66 (e.g., pointed distal end 66, as shown), and a penetration portion 70a adjacent distal end 66.
- penetrator 14a can also include an enlarged head (similar to enlarged head 58 of penetrator 14).
- penetration portion 70a has a length 74a that is a minority of the length of penetrator 14a between proximal end 54 and distal end 66.
- penetrator 14a has a transverse dimension of less than 1.2 mm (e.g., between 1 mm and 1.1 mm; less than 1.1 mm, less than 1.05 mm, less than 1 mm; less than, or between any two of, 0.5, 0.6, 0.7, 0.8, 0.9, and/or 1 mm).
- penetration portion 70a has a circular cross-section with a diameter 78a of between 1 and 1.2 mm (e.g., 1.04 mm).
- penetrator 14a is configured to be disposed in channel 34 of cannula 18 such that penetrator 14 is movable between a (1) retracted position (e.g., in which distal end 66 of the penetrator does not extend beyond second end 30 of the cannula) and (2) an extended position in which distal end 66 of the penetrator extends beyond second end 30 of the cannula by a penetration distance 82, which may, for example, be at least (e.g., greater than) 5 mm (e.g., 7 mm, 8 mm, 8-10 mm, more than 10 mm) and/or at least (e.g., greater than) 5 times (e.g., greater than, or between any two of: 6, 7, 8, 9, 10, or more times) a transverse dimension (e.g., diameter) of penetrator 14 (e.g., diameter 78a of penetration portion 70).
- a penetration distance 82 which may, for example, be at least (e.g.,
- penetration distance 82 is between 8 mm and 10 mm (e.g., 10 mm), which is greater than 7 times diameter 78a.
- the length of the penetration portion is greater than a penetration distance 82 for which the penetrator is designed.
- length 74a is greater than the penetration distance 82 (e.g., and greater than the sum of penetration distance 82 and the length of distal portion 42 of cannula 14 and/or cannula 14a).
- diameter 50 of primary portion 38 is larger than diameter 78a of penetration portion 70a, and/or equal to or greater than 1.2 mm (e.g., substantially equal to 1.27 mm) and/or less than 2.0 mm.
- diameter 50 is also less than 1.2 mm (e.g., between 1 mm and 1.1 mm, less than 1.1 mm, less than 1.05 mm).
- diameter 50 is substantially equal to diameter 78.
- penetrator 14 comprises a central wire defining transverse dimension 78a that is encircled or encased by an outer tubing (e.g., metallic tubing, plastic shrink wrap, and/or the like along the length of primary portion 62a to define transverse dimension 50a.
- an outer tubing e.g., metallic tubing, plastic shrink wrap, and/or the like along the length of primary portion 62a to define transverse dimension 50a.
- penetration portion 70a differs from penetration portion 70 in that penetration portion 70a is configured to reduce (e.g., relative to that of penetration portion 70) the force required to insert distal end 66 into a bone, and to reduce (e.g., relative to that of penetration portion 70) the force required to remove distal end 66 from the bone.
- penetration portion 70 includes a narrow portion 200 between distal end 66 and primary portion 62, with narrow portion 200 being narrower in at least one transverse dimension than primary portion 62.
- narrow portion 200 is configured to reduce the surface area of penetration portion 70a that is in contact with bone when the penetration portion is driven into a bone.
- the enlarged part of penetration portion 70a adjacent distal end 66 creates a path through the bone during insertion that is larger than narrow portion 200, such that at least a part of narrow portion 200 is not (at least initially) in contact with the bone. Even if penetration portion 70a remains in the bone for a sufficient time for the bone to rebound towards narrow portion 200, the reduced transverse dimension of narrow portion 200 may reduce the interface pressure between the penetrator and the rebounded bone material.
- This reduced contact and/or reduced interface pressure can reduce the force required to remove distal end 66 from the bone (e.g., relative to the force required to remove from the same type of bone penetration portion 70 of penetrator 14, which has a circular cylindrical shape with constant diameter and cross-section along the length of penetration portion 70- i.e., does not include narrow portion 200).
- transverse dimension 78a is a first transverse dimension in the penetration portion, and a second transverse dimension 204 that is smaller than first transverse dimension 78a is between primary portion 62 and first transverse dimension 78a (in penetration portion 70a, as shown).
- second transverse dimension 204 is substantially constant along part of length 74.
- narrow portion 200 has a length 208 along which second transverse dimension 204 is substantially constant. In the embodiment shown, length 208 is between 20 percent and 35 percent of length 74a of penetration portion 70a.
- length 208 can be any suitable fraction or percentage of length 74a (e.g., less than any one of, or between any two of, 5, 10, 15, 20, 25, 30, 35, 40, 45, and/or 50 percent).
- first transverse dimension 78a is adjacent distal end 66 (i.e., closer to distal end 66 than to primary portion 62).
- the distance between distal end 66 and narrow portion 200 is less than length 208 of the narrow portion.
- narrow portion can be disposed at any suitable position along the length of penetration portion 70a.
- penetration portion 70a further includes a third transverse dimension 212 between narrow portion 200 and primary portion 62.
- third transverse dimension 212 is substantially equal to first transverse dimension 78a, but may differ in other embodiments.
- third transverse dimension is substantially constant along a proximal segment 214 of penetration portion 70a.
- penetrator 14a has a first cross-sectional shape and/or area at first transverse dimension 78a, a second cross-sectional shape and/or area at second transverse dimension 204, and the first cross-sectional shape and/or area is larger than (e.g., and, as shown, concentric to) the second cross-sectional shape and/or area.
- penetrator 14a has a first circular cross section at first transverse dimension 78a, and a second circular cross section at second transverse dimension 204 (e.g., with the first circular cross-section being substantially concentric with the second circular cross-section, as shown).
- penetrator 14a also has a circular cross-section at third transverse dimension 212.
- the penetrator, the penetration portion, and/or the narrow portion can have any suitable cross-sectional shapes (e.g., circle, square, triangular, rectangular, star, and/or the like), whether similar or dissimilar (e.g., the cross-sectional shape of the narrow portion may differ from the cross-sectional shape of the remainder of the penetration portion), such that the cross-sectional shape of the surface of area of the narrow portion that contacts bone during insertion is reduced.
- the penetration portion can have a circular cross-section and the narrow portion can have a rectangular cross-section.
- narrow portion 200 may be fluted.
- penetration portion 70a also differs from penetration portion 70 in that distal end 66 is configured to reduce (e.g., relative to that of penetration portion 70) the force required to insert distal end 66 into a bone, and to reduce (e.g., relative to that of penetration portion 70) the force required to remove distal end 66 from the bone.
- distal end 66 includes a pointed tip 216 with a cross-sectional shape defined by a tip angle 220 of 60 degrees or greater (e.g., substantially equal to 60 degrees, as shown).
- pointed tip 216 has a conical shape having a cross-sectional shape that is bisected by a central longitudinal axis 224 of penetration portion 70a.
- pointed tip 216 can have any suitable shape (e.g., a triangular or rectangular pyramid).
- tip angle 220 is greater than 60 degrees, greater than 90 degrees, and/or greater than 120 degrees (e.g., equal to 180 degrees, or substantially perpendicular to a longitudinal axis of an adjacent portion of penetration portion 70a).
- a tip angle 220 of 60 degrees reduces the length of the cone that defines pointed tip relative to the 30 degree tip angle of penetrator 14, and thereby reduces the surface area of the cone that is available to contact bone during insertion and removal.
- further increases in tip angle 220 will further reduce the surface area of a conical pointed that is available to contact bone.
- penetration portion 70a further includes a first radiused portion 228 (which may instead be linearly tapered) between pointed tip 216 (and first transverse dimension 78a) and narrow portion 200, and a second tapered portion 232 (which may instead be radiused) between proximal segment 214 and narrow portion 200, to reduce likelihood of the transitions in transverse dimension resulting in points along penetration portion 70a that might otherwise catch or resist insertion or removal of distal end 66 into or from bone.
- the tip can be rounded and/or can be defined by a single (e.g., planar) facet extending across the entire cross-section of the penetration portion.
- penetrator 14a is substantially straight prior to being disposed in channel 34 of cannula 18 or cannula 18b, such that inserting the penetrator into the cannula causes the penetration portion 70a of the penetrator to bend within channel 34 (between primary portion 38 or 38a and distal portion 42 or 42a).
- penetrator 14a may be resilient enough to (e.g., at least partially) return to its straight shape after removal from the cannula.
- FIG. 6 depicts a side cross-sectional view of a second embodiment 18a of the present cannulas.
- Cannula 18a is similar in many respects to cannula 18.
- cannula 18a has a first end 26, a second end 30, and a channel 34 extending between the first end and the second end.
- first and second ends should be understood as the locations of the beginning and end of the channel.
- cannula 18 has a primary portion 38a and a distal portion 42a, with primary portion 38a extending between first end 26 and distal portion 42a (e.g., a majority of the length of the cannula, as in the embodiment shown), and with distal portion 42a extending between primary portion 38 and second end 30.
- cannula 18a differs from cannula 18 in that in cannula 18a, distal portion 42a is not angled relative to primary portion 38a (distal portion 42a and primary portion 38a share a common central longitudinal axis).
- Primary portion 38a has a transverse dimension 300 (e.g., a diameter, in the embodiment shown).
- distal portion 42a is tapered between primary portion 38a and second end 30, as shown.
- distal portion 42a has a length 304 that is less than a length 308 of cannula 18a (e.g., less than 20 percent of length 308).
- the relative lengths of primary portion 38a and distal portion 42a can be any suitable sizes for various procedures and/or for patients of various ages and/or sizes.
- cannula 18a is bent to form a cannula with an angled distal portion, as described below.
- angle 46b is substantially equal to 15 degrees.
- angle 46b can be between 5 degrees and 20 degrees (e.g., substantially equal to either of, or between, 10 degrees and 15 degrees).
- angle 46b can be greater than 60 degrees (e.g., equal to, or between any two of: 60, 70, 80, 90, and/or more degrees).
- distal portion 42b can include a curved or hooked shape such that angle 46b is effectively larger than 90 degrees (e.g., equal to, or between any two of: 90, 120, 150, 180, and/or 180 degrees).
- FIGS. 7A and 7B also include dimensions (in inches) for at least one exemplary embodiment of the present cannulas. Further, the difference between cannula 18a of FIG. 6 and cannula 18b of FIGS. 7A and 7B illustrate an embodiment of the present methods. In particular, some embodiments of the present methods (e.g., of making the present cannulas) comprise forming cannula 18b by bending (e.g., with a jig or the like) cannula 18a to angle 46.
- FIGS. 8A-8C depict various views of handle 22.
- FIGS. 8B includes dimensions (in inches) for at least one exemplary embodiment of the present handles.
- handle 22 comprises a central longitudinal passage 312 configured to receive part of a primary portion (e.g., 38, 38a) of a cannula (e.g., 18, 18a, 18b), such as, for example, via a press fit or the like.
- a primary portion e.g., 38, 38a
- a cannula e.g., 18, 18a, 18b
- FIG. 9 depicts an exploded perspective view of a kit 400 comprising an embodiment 10 of the present apparatuses and a package 404 for the apparatus.
- package 404 comprises a lower panel 408, a foam or other (e.g., molded plastic) receptacle 412 configured to receive apparatus 10 (including penetrator 14 and cannula 18), and an upper panel 416.
- kit 400 also includes instructions 420 and a box 424. As indicated by the arrangement of panels 408 and 416, receptacle 412, and instructions 420, these components fit into box 424.
- cannula 18 (including handle 22) and/or penetrator 14 are sterile and/or sealed in plastic independently of receptacle 412.
- FIGS. 10A-10D depict various views of another embodiment 10b of the present apparatuses that includes a penetrator removal tab 500 in combination with a penetrator 14b and a fourth embodiment 18c of the present cannulas.
- tab 500 comprises a body 504 with a first end 508, a second end 512, a distal side 516, and a proximal side 520.
- distal side 516 is configured to face toward second end 30 of cannula 18c, and comprises a protrusion 524 configured to contact handle 22 to act as a fulcrum during use, as described in more detail below.
- distal side 520 includes a plurality of grooves 528 to contact and resist slippage of a user's thumb during use.
- grooves 528 may be omitted and/or substituted with a different type of texture.
- body 504 has a curved or arcuate shape such that distal side 516 is concave and proximal side 520 is convex.
- body 504 includes an elongated opening 532 that is closer to first end 508 than to second end 512, and that is configured to receive enlarged head 58 of penetrator 14a as shown in FIGS. 10B and 10C .
- opening 516 can have a width (smaller transverse dimension) that is between 100% and 150% (e.g., between any two of: 100%, 110%, 120%, 130%, 140%, and 150%) of a corresponding transverse dimension (e.g., diameter 106) of enlarged head 58, and/or can have a height (larger transverse dimension) that is between 150% and 250% (e.g., between any two of: 150%, 175%, 200%, 225%, and 250%) of a corresponding transverse dimension (e.g., diameter 106) of enlarged head 58.
- opening 532 permits tab 500 to pivot relative to enlarged head 58 (and overall penetrator 14b) to apply an axial removal force to penetrator 14b while minimizing any lateral force that might otherwise deflect and/or impede movement of the penetrator.
- proximal side 520 of body 504 also includes a recess 536 configured to at least partially receive FIG. 10C ) a corresponding flange 542 that is coupled to (e.g., unitary with) enlarged head 58.
- flange 542 is configured to be disposed over and coupled in fixed relation to proximal end 54 and enlarged head 58 of penetrator 14b.
- flange 542 includes a neck 546 configured to be crimped and/or adhered via adhesive to enlarged head 58.
- flange 542 may be unitary with enlarged head.
- flange 542 has a transverse dimension (e.g., diameter) that is larger than a corresponding transverse dimension (e.g., diameter) of opening 504 but smaller than a corresponding transverse dimension of recess 536.
- enlarged head 58 is omitted and flange 542 and opening 528 (e.g., and recess 532) also limits the maximum penetration distance 82.
- a penetrator 14b (e.g., having flange 542 coupled to enlarged head 58) can be inserted through opening 528 and into cannula 18c such that tab 500 is disposed between flange 542 and handle 22a of cannula 18c. Second end 30 of cannula 18c can then be disposed in a desired location relative to a bone, and penetrator 14b can be impacted to drive distal end 66 of the penetrator into the bone.
- a user can apply a force to proximal side 520 of tab 500 in direction 550 (toward second end 30 of cannula 18c) to cause tab 500 to pivot around protrusion 524 and apply a force to flange 542 to retract the penetrator in direction 524.
- protrusion 524 is sized such that a second part of tab 500 (504) will also contact handle 22a at point 558 (such that protrusion once the penetrator is retracted by a distance about equal to or just larger than the maximum penetration distance (e.g., 82 of FIG.
- limiting the retraction distance e.g., to between 100% and 120% of maximum penetration distance 82 in this way can minimize the lateral force applied to enlarged head 58 during retraction of the penetrator and can facilitate reinsertion of the penetrator in a new location by minimizing the distance the penetrator must be advanced to bring its distal end (66) into initial contact with the bone at the new location.
- handle 22a is substantially similar to handle 22 with the exception that handle 22a includes a protrusion 562 that is aligned with distal portion 42 of cannula 18c.
- handle 22a includes a protrusion 562 that is aligned with distal portion 42 of cannula 18c.
- primary portion 38 of cannula 18c, distal portion 42 of cannula 18c, and protrusion 562 of handle 22d are each bisected by a single common plane.
- Protrusion 562 thus provides an indicator for a user of the orientation of distal portion 42 (e.g., even when distal portion 42 is disposed within a patient and out of the user's sight).
- any suitable indicator may be used (e.g., a depression instead of a protrusion, an arrow printed or painted on handle 22, and/or the like).
- penetrator 18 and/or channel 34 can have any suitable cross-sectional shape (e.g., triangular, square, rectangular, and/or the like) that permits the present apparatuses and methods to function as described in this disclosure.
- components may be combined as a unitary structure, and/or connections may be substituted.
- aspects of any of the examples described above may be combined with aspects of any of the other examples described to form further examples having comparable or different properties and addressing the same or different problems.
- the benefits and advantages described above may relate to one embodiment or may relate to several embodiments.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Claims (17)
- Vorrichtung (10), umfassend:eine Kanüle (18) mit einem ersten Ende, einem zweiten Ende und einem Kanal (34), der sich zwischen dem ersten Ende (26) und dem zweiten Ende (30) erstreckt;einen Penetrator (14) mit einem distalen Ende (66) und einer ersten Querabmessung, wobei der Penetrator (14) so konfiguriert ist, um in dem Kanal (34) der Kanüle (18) angeordnet zu sein, so dass der Penetrator (14) beweglich ist zwischen einer zurückgezogenen Position und einer ausgefahrenen Position, in der das distale Ende (66) über das zweite Ende (30) der Kanüle (18) um eine Eindringdistanz (82) von mindestens 5 mm hinausragt;wobei der Penetrator (14) so konfiguriert ist, dass er im Wesentlichen ohne Rotation des Penetrators (14) von der zurückgezogenen Position in die ausgefahrene Position bewegt wird, um im subchondralen Knochen eine Mikrofraktur mit einer Tiefe von mindestens 5 mm zu bilden;wobei der Penetrator (14) optional mindestens eines aus einem biokompatiblen Metall, einer Nickel-Titan-Legierung, rostfreiem Stahl und 316L-Edelstahl umfasst;dadurch gekennzeichnet, dass die erste Querabmessung weniger als 1,2 Millimeter (mm) beträgt.
- Vorrichtung nach Anspruch 1, dadurch gekennzeichnet, dass sie weiterhin umfasst:eine Penetratorentfernungslasche (500), die mit dem Penetrator (14) gekoppelt ist und konfiguriert ist, um den Penetrator (14) relativ zu der Kanüle (18) zurückzuziehen.
- Vorrichtung nach Anspruch 2, dadurch gekennzeichnet, dass
die Kanüle (18) einen Griff (22) aufweist,
der Penetrator (14) einen Flansch aufweist,
wobei die Penetratorentfernungslasche (500) eine Öffnung umfasst, die mindestens eine Querabmessung hat, die kleiner ist als eine Querabmessung des Flansches; und die Penetratorentfernungslasche (500) konfiguriert ist, um zwischen dem Griff (22) und dem Flansch angeordnet zu sein, wobei sich der Penetrator (14) durch die Öffnung erstreckt. - Vorrichtung nach Anspruch 3, dadurch gekennzeichnet, dass die Penetratorentfernungslasche (500) einen Vorsprung (524) umfasst, der konfiguriert ist, um sich in Richtung des zweiten Endes der Kanüle zu erstrecken und um mit dem Griff (22) in Kontakt zu stehen, um als ein Drehpunkt zum Schwenken der Penetratorentfernungslasche (500) zu wirken.
- Vorrichtung nach einem der Ansprüche 1 - 4, dadurch gekennzeichnet, dass die erste Querabmessung des Penetrators weniger als 1,1 Millimeter (mm) beträgt und/oder dass der Penetrator (14) so konfiguriert ist, um manuell von der zurückgezogenen Position in die ausgefahrene Position bewegt zu werden.
- Vorrichtung nach einem der Ansprüche 1 - 5, dadurch gekennzeichnet, dass der Penetrator (14) einen vergrößerten Kopf (58) aufweist und die Eindringdistanz (82) dadurch begrenzt ist, dass der vergrößerte Kopf (58) die Kanüle (18) berührt und optional dass der Penetrator einen länglichen Körper umfasst und der vergrößerte Kopf (58) mit dem länglichen Körper verbunden ist und optional weiterhin, dass der vergrößerte Kopf einstückig mit dem länglichen Körper ist.
- Vorrichtung nach Anspruch 6, dadurch gekennzeichnet, dass die Kanüle (18) einen ausgesparten Abschnitt (86) und eine Anlagefläche (90) aufweist, wobei sich der ausgesparte Abschnitt (86) von dem ersten (26) Ende der Kanüle (18) zu dem zweiten Ende (30) der Kanüle (18) erstreckt, wobei die Anlagefläche (90) zwischen dem ausgesparten Abschnitt (86) und dem zweiten (30) Ende der Kanüle (18) derart angeordnet ist, dass die Eindringdistanz (82) dadurch begrenzt wird, dass der vergrößerte Kopf die Anlagefläche (90) berührt, und optional dass der ausgesparte Abschnitt (86) eine Tiefe aufweist, die mindestens so groß ist wie die Eindringdistanz (82), und weiterhin optional, dass der vergrößerte Kopf (58) eine zylindrische Form mit einer Länge hat und mit einer Querabmessung, die kleiner als die Länge ist und weiterhin optional, dass der vergrößerte Kopf (58) eine Querabmessung hat, die mindestens 90% einer entsprechenden Querabmessung des ausgesparten Abschnittes beträgt.
- Vorrichtung nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass das distale Ende des Penetrators spitz ist.
- Vorrichtung nach einem der Ansprüche 1 - 8, dadurch gekennzeichnet, dass eine Beschichtung auf mindestens einem Penetrationsabschnitt (70) des Penetrators (14) aufgebracht ist oder dass eine hydrophile Beschichtung auf mindestens dem Penetrationsabschnitt (66) des Penetrators (14) aufgebracht ist, oder dass eine hydrophile Silberionen enthaltende Beschichtung mindestens auf dem Penetrationsabschnitt (66) des Penetrators (14) aufgebracht ist.
- Vorrichtung nach einem der Ansprüche 1 - 9, dadurch gekennzeichnet, dass der Penetrator (14) einen primären Abschnitt (62) und einen Penetrationsabschnitt (70) aufweist, wobei der primäre Abschnitt (62) einen kreisförmigen Querschnitt aufweist, wobei der Penetrationsabschnitt (70) zwischen dem primären (62) Abschnitt und dem distalen Ende (66) angeordnet ist, wobei der Penetrationsabschnitt (70) einen kreisförmigen Querschnitt aufweist, der kleiner als der kreisförmige Querschnitt des primären Abschnitts (62) ist.
- Vorrichtung nach Anspruch 10, dadurch gekennzeichnet, dass sich die erste Querabmessung in dem Penetrationsabschnitt (70) befindet und eine zweite Querabmessung, die kleiner als die erste Abmessung ist, zwischen der ersten Querabmessung und dem primären Abschnitt ist, oder dass die erste Querabmessung in dem Penetrationsabschnitt ist und eine Länge aufweist, und eine zweite Querabmessung, die kleiner als die erste Abmessung ist, zwischen der ersten Querabmessung und dem primären Abschnitt und im Wesentlichen konstant entlang eines Teils der Länge des Penetrationsabschnitts ist.
- Vorrichtung nach einem der Ansprüche 1 - 11, dadurch gekennzeichnet, dass der Penetrationsabschnitt (66) einen schmalen Abschnitt umfasst mit mindestens einer Querabmessung, die kleiner ist als eine benachbarte Querabmessung des Penetrationsabschnitts (70), so dass der schmale Abschnitt konfiguriert ist, um den Kontakt zwischen dem Penetrator (14) und einem Knochen zu verringern, wenn der Penetrationsabschnitt (70) in den Knochen eingeführt wird, oder dass der Penetrator (14) einen primären Abschnitt (62) und einen zwischen dem primären Abschnitt (62) und dem distalen Ende (66) angeordneten Penetrationsabschnitt (70) aufweist, wobei die erste Querabmessung in dem Penetrationsabschnitt (70) ist, und eine zweite Querabmessung zwischen der ersten Querabmessung und dem primären Abschnitt (62) ist.
- Vorrichtung nach Anspruch 12, dadurch gekennzeichnet, dass die zweite Querabmessung kleiner als die erste Querabmessung ist, oder dass die zweite Querabmessung kleiner als die erste Querabmessung ist, wobei der Penetrationsabschnitt (66) eine Länge hat, und die zweite Querabmessung im Wesentlichen über einen Teil der Länge des Penetrationsabschnitts (66) konstant ist.
- Vorrichtung nach Anspruch 13, dadurch gekennzeichnet, dass die erste Querabmessung näher an dem distalen Ende als an dem primären Abschnitt (62) ist, oder dass die erste Querabmessung näher an dem distalen Ende (66) als an dem primären Abschnitt (62) ist und wobei der Penetrator (14) eine erste, optional kreisförmige Querschnittsfläche an der ersten Querabmessung aufweist, der Penetrator (14) eine zweite, optional kreisförmige Querschnittsfläche an der zweiten Querabmessung aufweist, und die erste Querschnittsfläche größer ist als die zweite Querschnittsfläche.
- Vorrichtung nach einem der Ansprüche 1 - 14, dadurch gekennzeichnet, dass das distale Ende eine spitz zulaufende Spitze aufweist mit einer Querschnittsform, die durch einen spitzen Winkel von 60 Grad oder größer definiert ist, oder dass das distale Ende eine spitz zulaufende Spitze mit einer Querschnittsform aufweist, die durch einen spitzen Winkel von 60 Grad oder mehr definiert ist, wobei der spitze Winkel durch eine zentrale Längsachse des Penetrationsabschnitts (66) halbiert ist.
- Vorrichtung nach Anspruch 15, dadurch gekennzeichnet, dass der spitze Winkel größer als 90 Grad ist oder dass der spitze Winkel größer als 120 Grad ist.
- Ausrüstung, umfassend:die Vorrichtung (10) nach einem der Ansprüche 1 - 16;ein wiederverwendbares, sterilisierbares Tablett; undeine Verpackung, in der die Kanüle und die Schale versiegelt sind.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261609053P | 2012-03-09 | 2012-03-09 | |
US201261665084P | 2012-06-27 | 2012-06-27 | |
US201261720778P | 2012-10-31 | 2012-10-31 | |
US201261736913P | 2012-12-13 | 2012-12-13 | |
US201361755783P | 2013-01-23 | 2013-01-23 | |
PCT/US2013/029596 WO2013134500A1 (en) | 2012-03-09 | 2013-03-07 | Microfracture apparatuses and methods |
EP13714735.1A EP2822483B1 (de) | 2012-03-09 | 2013-03-07 | Mikrofrakturvorrichtungen |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13714735.1A Division EP2822483B1 (de) | 2012-03-09 | 2013-03-07 | Mikrofrakturvorrichtungen |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2987458A1 EP2987458A1 (de) | 2016-02-24 |
EP2987458B1 true EP2987458B1 (de) | 2018-10-31 |
Family
ID=48050242
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13714735.1A Active EP2822483B1 (de) | 2012-03-09 | 2013-03-07 | Mikrofrakturvorrichtungen |
EP15185091.4A Active EP2987458B1 (de) | 2012-03-09 | 2013-03-07 | Mikrofrakturvorrichtungen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13714735.1A Active EP2822483B1 (de) | 2012-03-09 | 2013-03-07 | Mikrofrakturvorrichtungen |
Country Status (6)
Country | Link |
---|---|
US (10) | US9211126B2 (de) |
EP (2) | EP2822483B1 (de) |
AU (1) | AU2013230914B2 (de) |
DK (2) | DK2987458T3 (de) |
PL (1) | PL2822483T3 (de) |
WO (1) | WO2013134500A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150359586A1 (en) * | 2000-02-03 | 2015-12-17 | Michael Heggeness | Device and method for alleviation of pain |
US8388624B2 (en) | 2003-02-24 | 2013-03-05 | Arthrosurface Incorporated | Trochlear resurfacing system and method |
EP1765201A4 (de) | 2004-06-28 | 2013-01-23 | Arthrosurface Inc | System für den gelenkflächenersatz |
CA2686814A1 (en) | 2006-12-11 | 2008-06-19 | Arthrosurface Incorporated | Retrograde resection apparatus and method |
US10172626B2 (en) | 2008-04-15 | 2019-01-08 | The Lonnie and Shannon Paulos Trust | Tissue microfracture apparatus and methods of use |
US10945743B2 (en) | 2009-04-17 | 2021-03-16 | Arthrosurface Incorporated | Glenoid repair system and methods of use thereof |
WO2010121250A1 (en) | 2009-04-17 | 2010-10-21 | Arthrosurface Incorporated | Glenoid resurfacing system and method |
CA2792048A1 (en) | 2010-03-05 | 2011-09-09 | Arthrosurface Incorporated | Tibial resurfacing system and method |
US20130165982A1 (en) | 2011-12-22 | 2013-06-27 | Arthrosurface Incorporated | System and Method for Bone Fixation |
US9211126B2 (en) * | 2012-03-09 | 2015-12-15 | Arthrosurface, Inc. | Microfracture apparatuses and methods |
DE112013003358T5 (de) | 2012-07-03 | 2015-03-19 | Arthrosurface, Inc. | System und Verfahren für Gelenkoberflächenersatz und -reparatur |
US9386997B2 (en) * | 2013-03-29 | 2016-07-12 | Smith & Nephew, Inc. | Tunnel gage |
US9492200B2 (en) | 2013-04-16 | 2016-11-15 | Arthrosurface Incorporated | Suture system and method |
CN105491975B (zh) | 2013-08-26 | 2018-09-28 | 医乐世医疗技术蒂默什达拉公司 | 牙钻*** |
ES2684083T3 (es) * | 2013-08-26 | 2018-10-01 | Elos Medtech Timmersdala Ab | Dispositivo de cirugía dental |
WO2015041888A1 (en) * | 2013-09-23 | 2015-03-26 | Sikora George J | Microfracture apparatuses |
US9931219B2 (en) | 2014-03-07 | 2018-04-03 | Arthrosurface Incorporated | Implant and anchor assembly |
US10624748B2 (en) | 2014-03-07 | 2020-04-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
US11607319B2 (en) | 2014-03-07 | 2023-03-21 | Arthrosurface Incorporated | System and method for repairing articular surfaces |
WO2016053730A1 (en) | 2014-10-01 | 2016-04-07 | Steven Ek | Apparatus for applying a membrane |
KR101825270B1 (ko) | 2015-10-26 | 2018-02-02 | 아주대학교산학협력단 | 미세골절술용 천공기구 |
WO2018058126A1 (en) * | 2016-09-26 | 2018-03-29 | Klsmc Instruments, Llc | Arthroscopic drill blade and arthroscopic drill access system made therefrom |
US10874406B2 (en) | 2017-02-28 | 2020-12-29 | MFr Technologies, Inc. | Handheld surgical instrument |
US11160663B2 (en) | 2017-08-04 | 2021-11-02 | Arthrosurface Incorporated | Multicomponent articular surface implant |
EP3735204B1 (de) | 2018-01-02 | 2023-09-06 | Cartiheal (2009) Ltd. | Implantationswerkzeug für optimierte solide substrate zur förderung von zell- und gewebewachstum |
KR101842419B1 (ko) | 2018-01-25 | 2018-05-14 | 아주대학교산학협력단 | 미세골절술용 천공기구 |
US11452517B2 (en) | 2018-06-04 | 2022-09-27 | West Gen Technologies, L.L.C. | Fixation device cartridges |
GB2609338B (en) | 2019-03-12 | 2023-06-14 | Arthrosurface Inc | Humeral and glenoid articular surface implant systems and methods |
USD929586S1 (en) * | 2019-06-03 | 2021-08-31 | West Gen Technologies, L.L.C. | Guide tool |
Family Cites Families (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2423511A (en) | 1946-03-12 | 1947-07-08 | Raymond R Luben | Self-centering awl |
US3943932A (en) | 1975-01-17 | 1976-03-16 | Yen Kong Woo | Acupuncture needles and holder |
FR2525473A2 (fr) | 1981-12-16 | 1983-10-28 | Ohana Gilbert | Aiguille d'acupuncture |
US4616649A (en) | 1984-09-20 | 1986-10-14 | Becton, Dickinson And Company | Lancet |
US5049150A (en) | 1990-12-27 | 1991-09-17 | Zimmer, Inc. | Tool for gripping a bone fragment |
PL169210B1 (pl) | 1992-08-03 | 1996-06-28 | Przed Zagraniczne Htl | Przyrzad do nakluwania PL |
US5437675A (en) | 1993-06-11 | 1995-08-01 | Wilson; Franklin D. | Polygonal bone punch |
US5667509A (en) | 1995-03-02 | 1997-09-16 | Westin; Craig D. | Retractable shield apparatus and method for a bone drill |
KR970050978U (ko) | 1996-02-23 | 1997-09-08 | 유태우 | 출혈침 |
US5695513A (en) * | 1996-03-01 | 1997-12-09 | Metagen, Llc | Flexible cutting tool and methods for its use |
US6692502B1 (en) | 1996-06-24 | 2004-02-17 | Janos Paul Ertl | Process and instrumentation for arthroscopic reduction of central and peripheral depression fractures |
US5741288A (en) | 1996-06-27 | 1998-04-21 | Chemtrak, Inc. | Re-armable single-user safety finger stick device having reset for multiple use by a single patient |
US5961535A (en) | 1996-10-17 | 1999-10-05 | Rosenberg; Thomas D. | Instrument and method for surgical stimulation of connective tissue |
DE69838856T2 (de) | 1997-02-11 | 2008-12-11 | Warsaw Orthopedic, Inc., Warsaw | Platte für die vordere Halswirbelsäule mit Fixierungssystem für eine Schraube |
US6146385A (en) | 1997-02-11 | 2000-11-14 | Smith & Nephew, Inc. | Repairing cartilage |
KR100541994B1 (ko) | 1997-04-25 | 2006-04-12 | 술저 오소패디 악티엔게젤샤프트 | 연골내 또는 골연골의 구멍을 만드는 장치 |
US6083238A (en) | 1997-09-23 | 2000-07-04 | Baxter International Inc. | Apparatus and method for improved aortic incision |
US6468279B1 (en) | 1998-01-27 | 2002-10-22 | Kyphon Inc. | Slip-fit handle for hand-held instruments that access interior body regions |
US6368326B1 (en) | 1998-09-28 | 2002-04-09 | Daos Limited | Internal cord fixation device |
CA2287757A1 (en) | 1999-10-29 | 2001-04-29 | Medical Plastic Devices M.P.D. Inc. | Disposable lancet |
ES2291228T3 (es) | 1999-12-03 | 2008-03-01 | The University Of Leeds | Reparacion de tejido dañado. |
US6322575B1 (en) | 2000-01-05 | 2001-11-27 | Steven Schraga | Lancet depth adjustment assembly |
EP2314257B9 (de) | 2000-05-01 | 2013-02-27 | ArthroSurface, Inc. | System zur Gelenkoberflächenerneuerung |
US6610067B2 (en) | 2000-05-01 | 2003-08-26 | Arthrosurface, Incorporated | System and method for joint resurface repair |
US7618462B2 (en) | 2000-05-01 | 2009-11-17 | Arthrosurface Incorporated | System and method for joint resurface repair |
US6679886B2 (en) | 2000-09-01 | 2004-01-20 | Synthes (Usa) | Tools and methods for creating cavities in bone |
DE60230306D1 (de) | 2001-10-01 | 2009-01-22 | Scandius Biomedical Inc | Gerät zur reparatur von gelenkknorpeldefekten |
US7241302B2 (en) | 2001-10-18 | 2007-07-10 | Tyco Healthcare Group Lp | Anastomosis instrument and method for performing same |
US20100268285A1 (en) | 2001-10-18 | 2010-10-21 | Orthoip, Llc | Bone screw system and method for the fixation of bone fractures |
US20040153005A1 (en) | 2002-01-03 | 2004-08-05 | Krueger John A. | Bone marrow aspiration device with curved tip |
US8641715B2 (en) | 2002-05-31 | 2014-02-04 | Vidacare Corporation | Manual intraosseous device |
US20050177071A1 (en) | 2002-09-05 | 2005-08-11 | Hiroshi Nakayama | Invasive appliance |
US6960214B2 (en) * | 2002-10-15 | 2005-11-01 | Zimmer Austin, Inc. | Method for performing automated microfracture |
US20040147932A1 (en) * | 2002-10-15 | 2004-07-29 | Brian Burkinshaw | Device for performing automated microfracture |
US8454639B2 (en) * | 2002-12-30 | 2013-06-04 | Cybersonics, Inc. | Dual probe with floating inner probe |
US20040260300A1 (en) | 2003-06-20 | 2004-12-23 | Bogomir Gorensek | Method of delivering an implant through an annular defect in an intervertebral disc |
US20050021067A1 (en) | 2003-07-25 | 2005-01-27 | Lhasa Oms, Inc. | Accupuncture needle insertion tube |
US7905898B2 (en) | 2003-08-15 | 2011-03-15 | Stat Medical Devices, Inc. | Adjustable lancet device and method |
US7338494B2 (en) | 2003-08-19 | 2008-03-04 | Synthes (U.S.A.) | Spring-loaded awl |
US7740633B2 (en) | 2003-10-23 | 2010-06-22 | Trans1 Inc. | Guide pin for guiding instrumentation along a soft tissue tract to a point on the spine |
US7879037B2 (en) * | 2004-02-11 | 2011-02-01 | Medtronic Xomed, Inc. | High speed surgical cutting instrument |
US7488322B2 (en) * | 2004-02-11 | 2009-02-10 | Medtronic, Inc. | High speed surgical cutting instrument |
US7967605B2 (en) * | 2004-03-16 | 2011-06-28 | Guidance Endodontics, Llc | Endodontic files and obturator devices and methods of manufacturing same |
US7163542B2 (en) | 2004-03-30 | 2007-01-16 | Synthes (U.S.A.) | Adjustable depth drill bit |
US7488323B2 (en) | 2004-11-23 | 2009-02-10 | Biomet Sports Medicine, Llc | Method and apparatus for manipulating bone during a surgical procedure |
US8066728B2 (en) | 2004-11-30 | 2011-11-29 | Stat Medical Devices, Inc. | Disposable or single-use lancet device and method |
DE102005010989A1 (de) * | 2005-03-03 | 2006-09-14 | Karl Storz Gmbh & Co. Kg | Medizinisches Instrument zum Einbringen von Mikrofrakturen in Knochen |
US8333776B2 (en) * | 2005-05-20 | 2012-12-18 | Neotract, Inc. | Anchor delivery system |
US7442197B2 (en) | 2005-05-23 | 2008-10-28 | Custom Spine, Inc. | Variable depth drill guide |
US8251998B2 (en) | 2006-08-16 | 2012-08-28 | Biomet Sports Medicine, Llc | Chondral defect repair |
US7942881B2 (en) * | 2006-03-15 | 2011-05-17 | Smith & Nephew, Inc. | Microfracture pick |
US7842038B2 (en) * | 2006-05-04 | 2010-11-30 | Warsaw Orthopedic, Inc. | Method for using retractable stylet and cannula combination to form an opening in bone |
US20080045964A1 (en) * | 2006-08-16 | 2008-02-21 | Allan Mishra | Device for cartilage repair |
US20100191195A1 (en) * | 2006-10-08 | 2010-07-29 | Ira Kirschenbaum | Cannulated apparatus and method relating to microfracture and revascularization methodologies |
US20080177266A1 (en) | 2006-10-18 | 2008-07-24 | Warsaw Orthopedic, Inc. | Adjustable height rasp |
US8337499B2 (en) * | 2006-10-30 | 2012-12-25 | Dgimed Ortho, Inc. | Surgical cutting devices and methods |
WO2008052367A1 (de) | 2006-10-31 | 2008-05-08 | Ao Technology Ag | Method and device for measuring the local mechanical resistance of a porous body |
US9237916B2 (en) * | 2006-12-15 | 2016-01-19 | Gmedeleware 2 Llc | Devices and methods for vertebrostenting |
ITRE20070053A1 (it) | 2007-04-12 | 2008-10-13 | Cgm Spa | '' strumento chirurgico fresatore di osso '' |
US20080262383A1 (en) | 2007-04-17 | 2008-10-23 | Needletech Products, Inc. | Needle assembly with separable handle |
CA2692002A1 (en) | 2007-05-21 | 2008-11-27 | Aoi Medical Inc. | Articulating cavitation device |
USD581534S1 (en) | 2007-08-18 | 2008-11-25 | Baoku Liu Dong | Acupuncture tool with multiple needles |
KR100950990B1 (ko) * | 2007-09-14 | 2010-04-02 | 최길운 | 뼈 치료용 장치 |
AU2008316600B2 (en) * | 2007-10-25 | 2014-09-18 | Jeffery D. Arnett | Systems and methods for vertebral disc replacement |
US20090143782A1 (en) * | 2007-11-30 | 2009-06-04 | Levi James H | Microfracture surgery apparatus and method |
AR070764A1 (es) * | 2007-12-07 | 2010-05-05 | Pyng Medical Corp | Aparatos y metodos para introducir portales oseos |
US20110034930A1 (en) | 2008-02-29 | 2011-02-10 | Buschmann Michael D | Drill burr and method for performing holes in subchondral bone to promote cartilage repair |
US10172626B2 (en) | 2008-04-15 | 2019-01-08 | The Lonnie and Shannon Paulos Trust | Tissue microfracture apparatus and methods of use |
US20090274996A1 (en) * | 2008-05-05 | 2009-11-05 | Kenneth Miller | Bone cutting device and method of using same |
US8409230B2 (en) * | 2008-05-08 | 2013-04-02 | Pivot Medical, Inc. | Method and apparatus for performing arthroscopic microfracture surgery |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
US20090312782A1 (en) * | 2008-06-13 | 2009-12-17 | Maxwell Choongwon Park | Method and apparatus for repairing tendons |
JP5575777B2 (ja) | 2008-09-30 | 2014-08-20 | ディファイン, インコーポレイテッド | 椎骨骨折の治療に使用するシステム |
US20100087823A1 (en) | 2008-10-02 | 2010-04-08 | Kondrashov Dimitriy G | Pedicle preparation device to assist implantation of pedicle screws |
US9060748B2 (en) * | 2009-03-18 | 2015-06-23 | Smith & Nephew, Inc. | Soft tissue manipulator assembly |
EP2236100B1 (de) * | 2009-03-30 | 2017-06-28 | Arthrex, Inc. | Mikrobruchinstrument |
US9414864B2 (en) * | 2009-04-15 | 2016-08-16 | Warsaw Orthopedic, Inc. | Anterior spinal plate with preformed drug-eluting device affixed thereto |
CA2802554A1 (en) * | 2009-06-16 | 2010-12-23 | Marc Beauchamp | Method and apparatus for arthroscopic rotator cuff repair using transosseous tunnels |
US8394102B2 (en) * | 2009-06-25 | 2013-03-12 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
US8911474B2 (en) * | 2009-07-16 | 2014-12-16 | Howmedica Osteonics Corp. | Suture anchor implantation instrumentation system |
AU2010278867B2 (en) | 2009-07-30 | 2015-10-01 | Smith & Nephew, Inc. | Instrument for creating microfractures in a bone |
EP2470257B1 (de) * | 2009-08-27 | 2015-03-04 | Silver Bullet Therapeutics Inc. | Knochenimplantate zur Behandlung einer Infektion |
US8674787B2 (en) | 2009-09-14 | 2014-03-18 | Andrew Llc | Plural phase shifter assembly having wiper PCBs movable by a pivot arm/throw arm assembly |
US20110238069A1 (en) * | 2010-02-11 | 2011-09-29 | Arthrex, Inc. | Threaded hole forming device |
FR2957776B1 (fr) | 2010-03-23 | 2013-02-15 | Arnaud Andre Soubeiran | Dispositif de deplacement de tissus a l'interieur de l'organisme, notamment de tissus osseux, a vis travaillant en traction fixe et ecrou tournant |
US10058336B2 (en) | 2010-04-08 | 2018-08-28 | Dfine, Inc. | System for use in treatment of vertebral fractures |
US20120071876A1 (en) * | 2010-09-17 | 2012-03-22 | Stoll E Jordan | Microfracture awl |
WO2012064402A1 (en) * | 2010-11-12 | 2012-05-18 | Silver Bullet Therapeutics, Inc. | Bone implant and systems that controllably releases silver |
US9398918B2 (en) * | 2011-01-27 | 2016-07-26 | Smith & Nephew, Inc. | Stabilizing microfracture device |
DE102011013888A1 (de) * | 2011-03-07 | 2012-09-13 | Karl Storz Gmbh & Co. Kg | Medizinisches Einstechwerkzeug |
US20120271357A1 (en) * | 2011-04-21 | 2012-10-25 | Warsaw Orthopedic, Inc. | Tools and methods for the preparation of the facet joint |
DE102011100695B4 (de) | 2011-05-06 | 2013-10-31 | Richard Wolf Gmbh | Mikrofraktor |
US9198676B2 (en) * | 2011-07-26 | 2015-12-01 | Howmedica Osteonics Corp. | PCL guides for drilling tibial and femoral tunnels |
US20130138046A1 (en) | 2011-11-28 | 2013-05-30 | Zhong Feng | Safe Self-Destruction Syringe with Puncture Proof Protective Sleeve |
US9259230B2 (en) * | 2012-01-29 | 2016-02-16 | Smith & Nephew, Inc. | Microfracture pick |
US9211126B2 (en) | 2012-03-09 | 2015-12-15 | Arthrosurface, Inc. | Microfracture apparatuses and methods |
US8995255B2 (en) | 2012-08-03 | 2015-03-31 | Intel Corporation | Coverage adjustment in E-UTRA networks |
US8821494B2 (en) * | 2012-08-03 | 2014-09-02 | Howmedica Osteonics Corp. | Surgical instruments and methods of use |
WO2014045124A2 (en) * | 2012-09-07 | 2014-03-27 | Zimmer Knee Creations, Inc. | Instruments for controlled delivery of injectable materials into bone |
US9078740B2 (en) * | 2013-01-21 | 2015-07-14 | Howmedica Osteonics Corp. | Instrumentation and method for positioning and securing a graft |
US9439947B2 (en) | 2014-03-28 | 2016-09-13 | Albert Einstein College Of Medicine, Inc. | Therapy for radiation-induced lung injury |
-
2013
- 2013-03-07 US US13/788,713 patent/US9211126B2/en active Active
- 2013-03-07 DK DK15185091.4T patent/DK2987458T3/en active
- 2013-03-07 DK DK13714735.1T patent/DK2822483T3/en active
- 2013-03-07 WO PCT/US2013/029596 patent/WO2013134500A1/en active Application Filing
- 2013-03-07 AU AU2013230914A patent/AU2013230914B2/en active Active
- 2013-03-07 EP EP13714735.1A patent/EP2822483B1/de active Active
- 2013-03-07 EP EP15185091.4A patent/EP2987458B1/de active Active
- 2013-03-07 PL PL13714735T patent/PL2822483T3/pl unknown
-
2015
- 2015-10-08 US US14/878,173 patent/US9572587B2/en active Active
- 2015-10-08 US US14/878,134 patent/US9510840B2/en active Active
-
2016
- 2016-12-05 US US15/369,350 patent/US9918721B2/en active Active
-
2017
- 2017-02-20 US US15/437,282 patent/US10039554B2/en active Active
-
2018
- 2018-02-13 US US15/895,209 patent/US10531880B2/en active Active
- 2018-08-03 US US16/054,510 patent/US10842506B2/en active Active
-
2020
- 2020-01-10 US US16/740,383 patent/US11376019B2/en active Active
- 2020-11-23 US US16/949,992 patent/US11678892B2/en active Active
-
2023
- 2023-05-05 US US18/313,090 patent/US20230355246A1/en active Pending
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
US20190201007A1 (en) | 2019-07-04 |
US20180271542A1 (en) | 2018-09-27 |
EP2987458A1 (de) | 2016-02-24 |
US9572587B2 (en) | 2017-02-21 |
US10842506B2 (en) | 2020-11-24 |
US20180008285A1 (en) | 2018-01-11 |
PL2822483T3 (pl) | 2016-05-31 |
DK2987458T3 (en) | 2019-02-11 |
US11376019B2 (en) | 2022-07-05 |
DK2822483T3 (en) | 2016-01-04 |
US20200367912A1 (en) | 2020-11-26 |
US9918721B2 (en) | 2018-03-20 |
US9211126B2 (en) | 2015-12-15 |
AU2013230914B2 (en) | 2018-02-01 |
US20160022280A1 (en) | 2016-01-28 |
US11678892B2 (en) | 2023-06-20 |
US9510840B2 (en) | 2016-12-06 |
AU2013230914A1 (en) | 2014-09-25 |
EP2822483B1 (de) | 2015-09-16 |
WO2013134500A1 (en) | 2013-09-12 |
US20160022279A1 (en) | 2016-01-28 |
US20210177436A1 (en) | 2021-06-17 |
EP2822483A1 (de) | 2015-01-14 |
US10039554B2 (en) | 2018-08-07 |
US20170303934A1 (en) | 2017-10-26 |
US20130317506A1 (en) | 2013-11-28 |
US10531880B2 (en) | 2020-01-14 |
US20230355246A1 (en) | 2023-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11678892B2 (en) | Microfracture apparatuses and methods | |
US12016574B2 (en) | Microfracture apparatuses and methods | |
US20230355406A1 (en) | Microfracture apparatuses and methods | |
EP2806806B1 (de) | Mikrofrakturierungspfriem | |
AU2014237438A1 (en) | Microfracture pick |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2822483 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
17P | Request for examination filed |
Effective date: 20160728 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 17/17 20060101ALI20171218BHEP Ipc: A61B 17/16 20060101AFI20171218BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180226 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAL | Information related to payment of fee for publishing/printing deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTC | Intention to grant announced (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20180727 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2822483 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1058433 Country of ref document: AT Kind code of ref document: T Effective date: 20181115 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013046169 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20190208 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190228 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190131 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190131 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190201 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190301 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013046169 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181031 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230515 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: UEP Ref document number: 1058433 Country of ref document: AT Kind code of ref document: T Effective date: 20181031 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20240321 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240320 Year of fee payment: 12 Ref country code: GB Payment date: 20240320 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240329 Year of fee payment: 12 Ref country code: DK Payment date: 20240326 Year of fee payment: 12 Ref country code: BE Payment date: 20240320 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240401 Year of fee payment: 12 |